The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

Amid escalating gang violence in Cape Town, Police Minister Firoz Cachalia argues that a state of emergency is not a simple solution. What are the long-term strategies needed to combat this crisis ...

The McFarland School District has received nearly $7,000 in unsolicited community donations to help eliminate unpaid student ...

Sexual abuse support services facing cuts in the new year have been given an extra six months, but are being told not to ...

Detailed price information for Evaxion A/S ADR (EVAX-Q) from The Globe and Mail including charting and trades.

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in asymptomatic patients.

Australian researchers have worked with global phamarceutical company MSD to co-develop a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially ...

Program Length: Minimum of 24 months Tuition: Approximately $69,588 per year. Additional fees apply. View tuition details. Degree/Certificate: M.S.D. Application Deadline: Rolling admission This ...

MSD (Merck & Co., Inc.) will vacate its laboratories at the Francis Crick Institute in London by end‑2025 as it winds down discovery research in the UK. The move follows the decision to scrap a ...